CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenues
Total revenues	$ 38,033,667	$ 29,464,849
Cost of revenues	17,079,069	14,753,042
Gross profit	20,954,598	14,711,807
Operating expenses
Selling, general and administrative	17,700,651	14,953,322
Depreciation and amortization	2,909,612	2,497,918
Total operating expenses	20,610,263	17,451,240
Income (loss) from operations	344,335	(2,739,433)
Other income
Interest income, net	790,917	28,297
Income (loss) before income tax provision	1,135,252	(2,711,136)
Income tax provision	107,477	10,198
Net income (loss)	$ 1,027,775	$ (2,721,334)
Basic	$ 0.02	$ (0.05)
Diluted	$ 0.02	$ (0.05)
Weighted average common shares
Basic	52,048,127	50,975,794
Diluted	52,933,255	50,975,794
Plasma Industry [Member]
Revenues
Total revenues	$ 34,737,640	$ 25,918,150
Pharmaceutical industry [Member]
Revenues
Total revenues	3,007,140	3,361,869
Other Revenue [Member]
Revenues
Total revenues	$ 288,887	$ 184,830